JMAR TECHNOLOGIES INC
424B3, 2000-02-15
MEASURING & CONTROLLING DEVICES, NEC
Previous: JMAR TECHNOLOGIES INC, 8-K, 2000-02-15
Next: MAXXIM MEDICAL INC, S-4/A, 2000-02-15



<PAGE>   1

PROSPECTUS SUPPLEMENT                                          File No. 33-47390
(To Prospectus Dated June 28, 1993)                Filed Pursuant to Rule 424(c)

                             JMAR TECHNOLOGIES, INC.

                        2,402,138 Shares of Common Stock

                                 $5.50 per Share

        This Prospectus Supplement supplements the Prospectus dated June 28,
1993 (the "1993 Prospectus") relating to the prior registration of the public
offering by the Company of shares of Common Stock of the Company issuable upon
exercise of Redeemable Common Stock Purchase Warrants ("JMARW Warrants"). The
1993 Prospectus also registered Underwriters' Units and Underwriters' Warrants
which have since expired.

        Information Incorporated by Reference:

        For more current information concerning the Company's business and
        financial condition, you are referred to the Company's Form 10-K for the
        year ended December 31, 1998, and Forms 10-Q for the quarters ended
        March 31, 1999, June 30, 1999 and September 30, 1999, each of which is
        incorporated into the Prospectus by reference.

        Amendment to JMARW Warrant Terms:

        As reflected in the Company's Form 8-K filed with the Commission on June
        17, 1998, the JMARW Warrants were amended in May, 1998 to provide for
        the following terms: (i) the Warrant exercise price was increased from
        $4.68 to $5.50 per share, (ii) the existing redemption provision was
        adjusted to provide that the Company may redeem any unexercised Warrants
        for $0.05 per Warrant if the average closing price of the Company's
        Common Stock is $7.00 or more over a period of ten consecutive trading
        days and (iii) the expiration date of the Warrants was extended to May
        15, 2000. As a result of subsequent exercises, a total of 2,402,138
        JMARW Warrants are outstanding as of February 11, 2000.

        Notice of Redemption:

        On February 15, 2000, the Company announced that it has exercised its
        right to call for redemption of its outstanding JMARW Warrants.
        Accompanying this Prospectus and Prospectus Supplement is a Notice of
        Redemption and related materials. As a result of the call, each JMARW
        Warrant will continue to be exercisable at $5.50 per warrant until 5:00
        p.m. (Eastern Standard Time) on


<PAGE>   2

        March 20, 2000. If a JMARW Warrant is exercised, the holder will receive
        one share of JMAR Common Stock. After 5:00 p.m. (Eastern Standard Time)
        on March 20, 2000, the JMARW Warrants will no longer be exercisable, and
        holders will receive only the redemption price of $0.05 per warrant.

        Warrant Solicitation Agent:

        The Company has appointed Auerbach, Pollak & Richardson, Inc.
        ("Auerbach") to act as warrant solicitation agent pursuant to a Warrant
        Solicitation Agreement, dated February 9, 2000, between the Company and
        Auerbach (the "Solicitation Agreement"). Pursuant to the Solicitation
        Agreement, in consideration for a broad range of services and advice
        related to the solicitation of exercises of the JMARW Warrants and the
        redemption call, the Company has agreed to pay Auerbach a cash fee of 5%
        of the total proceeds received from exercises of JMARW Warrants from and
        after the date the Notice of Redemption is issued. The Solicitation
        Agreement also provides that the Company will issue Auerbach a Warrant
        (the "Solicitor's Warrant") to purchase shares of the Company's Common
        Stock in an amount equal to eight percent (8%) of the JMARW Warrants
        exercised after February 9, 2000. The Solicitor's Warrant has an
        exercise price of $5.50 per share. The Solicitor's Warrant is not
        exercisable for at least six months following the issuance of the Notice
        of Redemption and thereafter shall only become exercisable on the first
        trading day after one of the following has occurred following said six
        month period: (x) the closing price (regular session) of the Company's
        Common Stock as reported by NASDAQ has exceeded $9.50 for any ten
        trading days in any twenty trading day period, or (y) the average of the
        closing price (regular session) of the Company's Common Stock as
        reported by NASDAQ for any ten consecutive trading day period exceeds
        $9.50. The Solicitor's Warrant will have a term of three years and a
        provision for cashless exercise. The Company has agreed to file a
        registration statement to include the shares issuable under the
        Solicitor's Warrant no later than the end of the six month period after
        the Redemption Date.







          The date of this Prospectus Supplement is February 15, 2000.


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission